Vascular acrosyndromes constitute a common reason for physician visits. From March 2006 to March 2008 we treated Carbomed CDT evolution device 40 patients (20 with Acrocyanosis and 20 with Raynaud phenomenon), with 1 session for week for a total of 5 weeks with a maintenance every 4 weeks. Treated patients showed benefit from the first session in the 80% of cases (court fine), In 10% of patients said they were partially satisfied with the treatment (court fine), in the remaining 10% sufficiently met (adequate trial). None reported a worsening of symptoms or the occurrence of adverse phenomena. In conclusion we can say that carbossiterapia is useful in the treatment of symptomatic vascular acrosindromi.
Campana, M., Vaccaro, M., Perello, R., Rosato, L., Ceccaccio, L., Ciappi, S., et al. (2009). The role of carbon dioxide in the treatment of symptomatic vascular acrosyndromes [Il ruolo della carbossiterapia nel trattamento sintomatico delle acrosindromi vascolari]. RIVISTA ITALIANA DI CHIRURGIA PLASTICA, 41(3-4), 159-163.
The role of carbon dioxide in the treatment of symptomatic vascular acrosyndromes [Il ruolo della carbossiterapia nel trattamento sintomatico delle acrosindromi vascolari]
CAMPANA, MATTEO;VACCARO, MARINA;ROSATO, LUCA;CECCACCIO, LAVINIA;CIAPPI, SERENA;BRAFA, ANNA;CALABRO', MASSIMILIANO;NISI, GIUSEPPE;BRANDI, CESARE;GRIMALDI, LUCA;D'ANIELLO, CARLO
2009-01-01
Abstract
Vascular acrosyndromes constitute a common reason for physician visits. From March 2006 to March 2008 we treated Carbomed CDT evolution device 40 patients (20 with Acrocyanosis and 20 with Raynaud phenomenon), with 1 session for week for a total of 5 weeks with a maintenance every 4 weeks. Treated patients showed benefit from the first session in the 80% of cases (court fine), In 10% of patients said they were partially satisfied with the treatment (court fine), in the remaining 10% sufficiently met (adequate trial). None reported a worsening of symptoms or the occurrence of adverse phenomena. In conclusion we can say that carbossiterapia is useful in the treatment of symptomatic vascular acrosindromi.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/11771
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo